Enhai Cui
Impact in
-
- MicroRNA in disease regulation
-
- Mesenchymal stem cell research
- Genetic Associations and Epidemiology
Papers in
- Co-authors
- Wei Mao (4 shared papers)Xueren Feng (3 shared papers)Xiang Wang (4 shared papers)Wenyan Chen (6 shared papers)Lu Lv (5 shared papers)Na Chen (4 shared papers)Hongjiao Li (1 shared paper)Xiang Wang (1 shared paper)
- Journals
- Journal of Cellular Biochemistry (3 papers)Frontiers in Microbiology (1 paper)World Journal of Stem Cells (1 paper)Anti-Cancer Drugs (1 paper)Oncology Reports (1 paper)
- Partner nations
- China
In The Last Decade
Enhai Cui
19 papers receiving 312 citations
Peers
Comparison fields: 5 of 48
- Cancer Research 80
- Genetics 49
- Clinical Biochemistry 23
- Oncology 42
- Epidemiology 41
Countries citing papers authored by Enhai Cui
This map shows the geographic impact of Enhai Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Enhai Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Enhai Cui more than expected).
Fields of papers citing papers by Enhai Cui
This network shows the impact of papers produced by Enhai Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Enhai Cui. The network helps show where Enhai Cui may publish in the future.
Co-authors
The 25 scholars most cited alongside Enhai Cui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 81 | |
| 2 | 2012 | 37 | |
| 3 | 2023 | 31 | |
| 4 | 2018 | 30 | |
| 5 | 2011 | 25 | |
| 6 | 2017 | 21 | |
| 7 | 2023 | 17 | |
| 8 | 2022 | 10 | |
| 9 | 2023 | 10 | |
| 10 | 2024 | 10 | |
| 11 | 2012 | 9 | |
| 12 | 2023 | 8 | |
| 13 | 2024 | 7 | |
| 14 | 2025 | 7 | |
| 15 | COUP-TFII promotes colorectal carcinoma resistance to doxorubicin involving inhibition of epithelial-mesenchymal transition [corrected]. | 2016 | 4 |
| 16 | 2023 | 4 | |
| 17 | 2015 | 2 | |
| 18 | 2022 | 2 | |
| 19 | 2023 | 2 | |
| 20 | 2024 | 0 |
About Enhai Cui
Enhai Cui is a scholar working on Genetics, Oncology, Epidemiology, Molecular Biology and Clinical Biochemistry, having authored 20 papers that have together received 317 indexed citations. Recurring topics across this work include Mesenchymal stem cell research (6 papers), Extracellular vesicles in disease (3 papers), Cancer Cells and Metastasis (2 papers), Adipokines, Inflammation, and Metabolic Diseases (2 papers), Lung Cancer Research Studies (2 papers), Lung Cancer Treatments and Mutations (1 paper), Pneumonia and Respiratory Infections (1 paper) and Berberine and alkaloids research (1 paper). The work is most often cited by research in Cancer Research (80 citations), Genetics (49 citations), Clinical Biochemistry (23 citations), Oncology (42 citations) and Epidemiology (41 citations). Enhai Cui has collaborated with scholars based in China. Frequent co-authors include Wei Mao, Xueren Feng, Xiang Wang, Wenyan Chen, Lu Lv, Na Chen, Hongjiao Li, Xiang Wang, Bin Wang and Ruolang Pan. Their work appears in journals such as Journal of Cellular Biochemistry, Frontiers in Microbiology, World Journal of Stem Cells, Anti-Cancer Drugs and Oncology Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.